Contribution of 92 kDa Gelatinase/Type IV Collagenase in Bronchial Inflammation during Status Asthmaticus
- 1 April 1999
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 159 (4) , 1298-1307
- https://doi.org/10.1164/ajrccm.159.4.9708080
Abstract
In order to assess inflammatory features related to severe asthma as compared with mild asthma, we investigated the secretion of 92 kDa gelatinase matrix metalloproteinase (MMP-9) in bronchial lavages of six patients undergoing mechanical ventilation (MV) for status asthmaticus (SA) and in six patients with mild asthma. Ten healthy nonventilated patients and four patients under MV without preexisting respiratory disease were also investigated. Patients with SA were characterized by prominent neutrophilic inflammation (82 +/- 4% versus 10% in mild asthma). On the basis of enzymatic and immunological analysis, results showed an acute 10- to 160-fold increase of 92 kDa gelatinase (MMP-9) concentration in epithelial lining fluid (ELF) from patients with SA, together with activated forms (46 and 26 kDa) of stromelysin-1 matrix metalloproteinase (MMP-3) and detectable concentration of free metallogelatinolytic activity (1-5 micrograms gelatin hydrolyzed/48 h/ml ELF). Concomitant elevated level of tissue inhibitor of metalloproteinase-1 (TIMP-1) was shown only in patients with SA, thus counterbalancing, at least partially, excess of activated 92 kDa gelatinase. Acutely enhanced albumin levels were only observed in patients with SA; in addition, 92 kDa gelatinase and albumin levels were significantly and positively correlated (r = 0.96, p < 0.0001), suggesting that 92 kDa gelatinase may account for increased bronchial permeability in patients with SA. Several arguments support that 92 kDa gelatinase during SA originates both from numerous activated chemoattracted neutrophils and from activated bronchial epithelial cells in response to in situ lung injury. The fact that no relevant change in ELF, albumin, MMP-9, MMP-3, TIMP-1, or laminin degradation products was observed during mild asthma, strongly supports that the mechanism of airway inflammation in SA is quite distinct from that observed in mild asthma.Keywords
This publication has 31 references indexed in Scilit:
- Expression of Matrix Metalloproteinase Gelatinases A and B by Cultured Epithelial Cells from Human Bronchial ExplantsJournal of Biological Chemistry, 1996
- Differential expression and secretion of gelatinases and tissue inhibitor of metalloproteinase-1 during neutrophil adhesionBiochimica et Biophysica Acta (BBA) - General Subjects, 1996
- Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbationJournal of Allergy and Clinical Immunology, 1995
- Activation of the 92-kDa Gelatinase by Stromelysin and 4-Aminophenylmercuric AcetateJournal of Biological Chemistry, 1995
- 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.Journal of Clinical Investigation, 1994
- Production and regulation of gelatinase B by human T-cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4.Journal of Clinical Investigation, 1992
- Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthmaJournal of Allergy and Clinical Immunology, 1991
- Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.Journal of Clinical Investigation, 1990
- SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICSThe Lancet, 1989